Valneva SE (VALN) Accounts Payables (2020 - 2026)

Valneva SE (VALN) posted quarterly Accounts Payables of $24.8 million for Q1 2026, down 21.66% year-on-year from $31.7 million in Q1 2025, and down 11.14% on a QoQ basis from $27.9 million in Q4 2025.

Valneva SE (VALN) Accounts Payables (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Accounts Payables for 7 consecutive years, with $24.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Accounts Payables fell 21.66% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.8 million (down 21.66% YoY) and the FY2025 annual result came in at $27.9 million, down 30.92% from the prior year.
  • Accounts Payables fell to $24.8 million in Q1 2026 per VALN's latest filing, from $27.9 million in the prior quarter.
  • Over the last five years, Accounts Payables for VALN reached as high as $107.2 million in Q3 2023 and fell as low as $24.0 million in Q2 2025.
  • A 5-year average of $52.1 million and a median of $40.4 million in 2024 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2023 — Accounts Payables advanced 25.7% — and 2024, when it tumbled 54.48%.
  • Year by year, Accounts Payables stood at $47.2 million in 2022, then climbed by 6.78% to $50.4 million in 2023, then slipped by 19.82% to $40.4 million in 2024, then sank by 30.92% to $27.9 million in 2025, then declined by 11.14% to $24.8 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $24.8 million, $27.9 million, and $34.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 24.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.81 Mn
Dec 31, 2025 27.93 Mn
Sep 30, 2025 34.27 Mn
Jun 30, 2025 24.03 Mn
Mar 31, 2025 31.67 Mn
Dec 31, 2024 40.42 Mn
Sep 30, 2024 48.81 Mn
Jun 30, 2024 37.15 Mn
Mar 31, 2024 38.13 Mn
Dec 31, 2023 50.41 Mn
Sep 30, 2023 107.24 Mn
Jun 30, 2023 78.69 Mn
Mar 31, 2023 38.14 Mn
Dec 31, 2022 47.21 Mn
Sep 30, 2022 85.32 Mn
Jun 30, 2022 95.25 Mn
Mar 31, 2022 75.41 Mn
Dec 31, 2021 77.52 Mn
Dec 31, 2020 41.21 Mn